McKesson | MCK - Cash And Equivalent

Stock Price
828.48
Daily Change
0.37 0.04%
Monthly
-3.69%
Yearly
18.40%
Q2 Forecast
810.39

McKesson reported $2.96B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Acadia Healthcare USD 133.24M 14.55M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Centene USD 17.89B 830M Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cigna USD 7.68B 1.65B Dec/2025
Community Health Systems USD 712M 452M Mar/2026
Computer Programs Systems USD 24.85M 4.93M Dec/2025
CVS Health USD 8.45B 645M Dec/2025
DaVita Healthcare Partners USD 676.44M 29.52M Dec/2025
Dentsply International USD 326M 37M Dec/2025
eHealth USD 63.09M 2.83M Sep/2025
Elevance Health USD 9.66B 166M Mar/2026
Encompass Health USD 72.2M 23.5M Dec/2025
HCA USD 940M 100M Mar/2026
Henry Schein USD 136M 9M Sep/2025
Humana USD 4.2B 1.19B Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
J&J USD 21.69B 1.98B Mar/2026
Laboratory Of America USD 532.3M 65.8M Dec/2025
McKesson USD 2.96B 1.05B Dec/2025
Molina Healthcare USD 5.31B 1.07B Mar/2026
Owens Minor USD 281.99M 249.15M Dec/2025
Quest Diagnostics USD 393M 27M Mar/2026
Stryker USD 4.01B 755M Dec/2025
Tenet Healthcare USD 2.88B 92M Dec/2025
UnitedHealth USD 31.23B 3.11B Mar/2026
Universal Health Services USD 137.8M 24.9M Dec/2025
Veradigm USD 492.6M 7.57M Sep/2022